INTRODUCTION {#s1}
============

Calcium (Ca^2+^) is an essential intracellular messenger in all organisms, from prokaryotes to humans. The ion binds to a diverse range of proteins, commonly at EF-hand or EF-hand-like domains, and promotes conformational and electrostatic alterations in these proteins. These interactions modulate their activity and contribute to a cascade of signaling events that ultimately defines a Ca^2+^-mediated cellular response to a stimulus ([@b15]). Cells mobilize Ca^2+^ to the cytosol by the opening of channels in the plasma membrane (for Ca^2+^ influx from the external medium) or in the membranes of organelles that act as intracellular stores. In fungi, Ca^2+^ uptake from the extracellular milieu can occur by different mechanisms, depending on the stimulus. The high-affinity Ca^2+^ uptake system (HACS) is the best described fungal Ca^2+^ uptake system. It comprises the channel Cch1 and the regulatory proteins Mid1 and Ecm7 ([@b56]; [@b60]). The exact role of Mid1 is unclear, as the protein has also been reported to behave as a non-selective stretch-activated cation channel protein in some systems ([@b12]; [@b46]; [@b54]). The HACS seems to be particularly active in minimal medium, whereas the low-affinity Ca^2+^ system (LACS) is more active in nutrient-rich medium ([@b60]). So far, the only known member of the LACS system is the Fig1 channel, which is involved in mating ([@b11]; [@b61]). A glucose-induced Ca^2+^ influx system was recently proposed ([@b34]) but its molecular components are unknown.

In tip-growing organisms such as the fungus *Neurospora crassa*, cytosolic free Ca^2+^ (\[Ca^2+^\]~c~) is important for polarized growth. Hyphal growth in *N. crassa* has been reported to rely on a tip-high \[Ca^2+^\]~c~ gradient that is not maintained by extracellular Ca^2+^ influx ([@b53]), but is internally derived by means of inositol-1,4,5-trisphosphate (IP~3~)-activated Ca^2+^ channels ([@b76]; [@b77]; [@b78]). Evidence indicates that IP~3~ is generated by a stretch-activated tip-localized phospholipase C that senses tension due to hyphal expansion and converts phosphatidylinositol-4,5-bisphosphate (PIP~2~) to IP~3~ and diacylglycerol (DAG) ([@b77]; [@b78]). IP~3~ promotes the release of Ca^2+^ through a large conductance channel, associated with the vacuolar membrane ([@b20]; [@b77]), and a small conductance channel, associated with endoplasmic reticulum (ER)- and Golgi-derived vesicles that have been proposed to accumulate near the hyphal tip ([@b77]). Only the latter is believed to be involved in the generation of the tip-high \[Ca^2+^\]~c~ gradient ([@b77]; [@b82]). However, a recognizable IP~3~ receptor has not yet been identified in fungi ([@b6]; [@b89]). The existence of a continuous tip-high \[Ca^2+^\]~c~ gradient in growing hyphae has recently been challenged ([@b49]). In this study, the imaging of \[Ca^2+^\]~c~, using a genetically encoded Ca^2+^ reporter expressed in *Fusarium* and *Magnaporthe*, demonstrated that \[Ca^2+^\]~c~ spikes with an irregular frequency occur in growing hyphal tips, with the result that the tip-focused gradient appears and disappears in hyphae extending at constant rates.

The phospholipase C pathway is the main modulator of transient receptor potential (TRP) channels, which are permeable to Ca^2+^. The TRP channel family comprises several subfamilies: classical (TRPC), vanilloid (TRPV), melastatin (TRPM), polycystin (TRPP), mucolipin (TRPML) and ankyrin (TRPA) ([@b73]). In *N. crassa*, the only known TRP-type channel is YVC-1 ([@b89]). In *Saccharomyces cerevisiae*, the homolog of YVC-1 is localized in the vacuolar membrane and is involved in the release of Ca^2+^ into the cytosol ([@b67]) after activation by stretch ([@b80]) and PIP~2~ ([@b24]). Recently, an *in silico* genomic comparison of fungal pathogens identified additional TRP channel homologs ([@b70]).

The alkaloid staurosporine was initially isolated from *Streptomyces staurosporeus* during a screen for protein kinase C inhibitors ([@b66]) and was later shown to behave as a broad kinase inhibitor ([@b47]). It is largely known to trigger cell death in mammalian models. Although staurosporine exhibits potent anticancer activity, the lack of selectivity and concomitant side effects makes it too toxic for drug therapy. However, the drug remains as an archetypal inducer of cell death and an anticancer agent. Some staurosporine analogs with improved selectivity profiles, such as UCN-01, CGP41251 or PKC412 are currently being evaluated in clinical trials ([@b29]; [@b31]), accentuating the need for understanding the mechanisms of action of this type of drug. We showed recently that *N. crassa* and pathogenic fungi are sensitive to staurosporine ([@b10]; [@b26]; [@b25]; [@b33]; [@b32]).

In this paper, we have used *N. crassa* cells expressing the codon-optimized, bioluminescent Ca^2+^ reporter aequorin ([@b4]; [@b63]; [@b83]) in order to analyze the role of Ca^2+^ signaling during the initiation of fungal cell death by staurosporine. We demonstrate that staurosporine promotes well-defined changes in \[Ca^2+^\]~c~ with a distinct Ca^2+^ signature and that phospholipase C is a pivotal player during the induction of cell death. The response to staurosporine includes both Ca^2+^ uptake from the extracellular milieu by a novel fungal influx system resembling a TRP channel that seems to be upregulated in the absence of the HACS and an IP~3~-mediated cytosolic recruitment of organelle-stored Ca^2+^.

RESULTS {#s2}
=======

Staurosporine induces a well-defined Ca^2+^ signature {#s2a}
-----------------------------------------------------

After 6 hours of culture, wild-type *N. crassa* cells expressing the codon-optimized bioluminescent \[Ca^2+^\]~c~ reporter aequorin ([@b63]) were incubated with 20 µM staurosporine, and the luminescence was monitored over time. Staurosporine induced a well-defined signature of \[Ca^2+^\]~c~ changes ([Fig. 1A](#f01){ref-type="fig"}). The signature included two major Ca^2+^ peaks that we identified as 'A' and 'B', and a third broad increase in cytosolic Ca^2+^ ('C'). Peak A occurred immediately upon addition of staurosporine and lasted for ∼20 minutes, and peak B, having the greatest amplitude, occurred after 35--40 minutes and lasted for ∼80 minutes. UCN-01, a natural stereoisomer of 7-hydroxystaurosporine currently in clinical trials for cancer treatment ([@b29]), also provoked an immediate peak of \[Ca^2+^\]~c~, although the overall Ca^2+^ signature was different from that caused by staurosporine ([Fig. 1A](#f01){ref-type="fig"}).

![**Staurosporine induces a well-defined Ca^2+^ signature.** (A) Aequorin-expressing wild-type cells grown for 6 hours were incubated with 20 µM staurosporine (STS) or 20 µM UCN-01, and the timecourse emission of luminescence was monitored over 5 hours. The STS-induced Ca^2+^ signature contained two major Ca^2+^ transients (phases 'A' and 'B') and a third broad \[Ca^2+^\]~c~ increase ('C') and represents an average of 30 independent experiments, each with three to six replicates. The 'staurosporine-induced amplitude of response' was calculated by subtracting the solvent DMSO control curve shown in this figure (this was also performed for the following [Figs 2](#f02){ref-type="fig"}--[](#f03){ref-type="fig"}[](#f04){ref-type="fig"}[](#f05){ref-type="fig"}[6](#f06){ref-type="fig"}). \[Ca^2+^\]~c~ measurements in [Figs 1](#f01){ref-type="fig"}--[](#f02){ref-type="fig"}[](#f03){ref-type="fig"}[](#f04){ref-type="fig"}[](#f05){ref-type="fig"}[6](#f06){ref-type="fig"} are also presented with errors bars in [supplementary material Fig. S1](http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.152058/-/DC1). (B) Cell death as a readout of membrane permeabilization was examined after staining with propidium iodide (PI). Data show the mean±s.e.m.; \**P*\<0.05.](jcs-127-17-3817-f01){#f01}

The levels of staurosporine-induced cell death, as measured by staining with propidium iodide, a reporter of plasma membrane permeabilization, were only significantly increased after 3 hours of incubation with the drug ([Fig. 1B](#f01){ref-type="fig"}; representative images of propidium iodide staining at different time-points are presented in [supplementary material Fig. S2A](http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.152058/-/DC1)). This supports the view that peaks A and B, that occur within the first 2 hours of treatment with staurosporine, correspond to specific Ca^2+^ signaling events upstream of cell death and do not involve non-specific Ca^2+^ entry into the cytosol due to plasma membrane disruption. The third phase (C) of the staurosporine-induced Ca^2+^ signature coincides with a significant increase in the percentage of propidium-iodide-positive cells ([Fig. 1B](#f01){ref-type="fig"}). Total available aequorin for Ca^2+^ detection was not affected by the drug throughout the entire length of the staurosporine-induced Ca^2+^ signature ([supplementary material Fig. S2B](http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.152058/-/DC1)).

The staurosporine-induced Ca^2+^ signature is derived from extracellular and internal Ca^2+^ stores {#s2b}
---------------------------------------------------------------------------------------------------

In *N. crassa*, free Ca^2+^ is stored in different intracellular organelles and in the cell wall, and its distribution depends on the growth phase ([@b8]; [@b62]; [@b82]). We aimed to identify the source(s) of Ca^2+^ that give rise to the staurosporine-induced \[Ca^2+^\]~c~ signature, and we started by looking at the contribution of extracellular Ca^2+^. Pre-incubation with the membrane-impermeable Ca^2+^-chelator BAPTA resulted in complete abolition of the \[Ca^2+^\]~c~ increases associated with the staurosporine-induced Ca^2+^ signature ([Fig. 2Ai,ii,E,F](#f02){ref-type="fig"}). BAPTA added at later time-points after the incubation with staurosporine (15, 40 or 180 minutes) abolished subsequent elevations in \[Ca^2+^\]~c~ of the Ca^2+^ signature ([Fig. 2Aiii--v](#f02){ref-type="fig"}). This indicates that Ca^2+^ influx occurs continuously throughout the staurosporine-induced Ca^2+^ signature. Because non-specific Ca^2+^ influx does not occur during phases A and B of the Ca^2+^ signature (see previous section), our results point to the presence of Ca^2+^-permeable channels in the plasma membrane that are involved in generating these \[Ca^2+^\]~c~ transients.

![**The staurosporine-induced Ca^2+^ signature results from Ca^2+^ influx into the cytosol from the extracellular medium and from internal Ca^2+^ stores.** (A) The influence of BAPTA on the Ca^2+^ signature after aequorin-expressing wild-type cells were treated with 20 µM staurosporine (STS). (i) No BAPTA control. (ii--v) 4 mM BAPTA was applied at the indicated time-points (arrows). The figures represent the staurosporine-induced amplitude of response. (B--D) The influence of 10 µM thapsigargin (B), 0.6 µM bafilomycin A1 (C) and 50 µM Ru360 (D) on the staurosporine-induced Ca^2+^ signature response in aequorin-expressing wild-type cells. (E,F) Quantification (in arbitrary units, A.U.) of the \[Ca^2+^\]~c~ transients A and B, respectively, which are shown in A--D. Data show the mean±s.e.m.; \**P*\<0.05.](jcs-127-17-3817-f02){#f02}

The contribution of the ER to the staurosporine-induced Ca^2+^ signature was evaluated by treating cells with the ER-selective Ca^2+^-ATPase inhibitor thapsigargin. Thapsigargin causes the depletion of ER Ca^2+^ and prevents Ca^2+^ sequestration by this organelle ([@b81]). Pre-treatment with thapsigargin changed the signature of the Ca^2+^ response to staurosporine and resulted in the absence of peak A ([Fig. 2B,E,F](#f02){ref-type="fig"}). Because Ca^2+^ in the ER is likely depleted by thapsigargin before the addition of staurosporine, this result is consistent with Ca^2+^ release from the ER contributing to peak A. However, inhibition of the ER Ca^2+^-ATPase resulted in an increase in the amplitude of peak B compared with that of the untreated control, suggesting that ER Ca^2+^-ATPase activity plays a significant role in sequestering Ca^2+^ during this second phase of \[Ca^2+^\]~c~ increase. The amplitude of the prolonged \[Ca^2+^\]~c~ elevation during phase C was also increased in cells that were pre-treated with thapsigargin, indicating that continued Ca^2+^-ATPase activity might also occur during this period.

In *N. crassa*, the vacuoles are responsible for the sequestration of Ca^2+^ under stress conditions to avoid the toxic accumulation of Ca^2+^ in the cytosol ([@b19]). We used bafilomycin A1 to assess whether the complex and heterogeneous vacuolar system in *N. crassa* ([@b8]) plays a role as a Ca^2+^ store during the staurosporine-induced Ca^2+^ signature. Bafilomycin A1 has previously been used to inhibit Ca^2+^ uptake by vacuoles and smaller acidic vesicles by blocking H^+^-ATPase activity, which results in disruption of the proton gradient required for Ca^2+^ uptake by the vacuolar Ca^2+^/H^+^ exchanger ([@b18]). The presence of bafilomycin A1 resulted in a \[Ca^2+^\]~c~ increase in peaks A and B but not during peak C following staurosporine treatment ([Fig. 2C,E,F](#f02){ref-type="fig"}). These results are consistent with the vacuolar system playing a role in sequestering Ca^2+^ during phases A and B of the staurosporine-induced Ca^2+^ response but, in contrast to the ER, not during phase C.

Mitochondria are also involved in Ca^2+^ sequestration. In mammalian cells, Ca^2+^ uptake by mitochondria occurs mainly through the mitochondrial Ca^2+^ uniporter (MCU), which is putatively homologous to the *N. crassa* protein NCU08166 ([@b3]). Pre-incubation with the MCU-specific inhibitor Ru360 ([@b88]) before the addition of staurosporine converted the \[Ca^2+^\]~c~ peaks associated with phases A and B into a single peak and caused the abolition of the extended increase in \[Ca^2+^\]~c~ during phase C ([Fig. 2D--F](#f02){ref-type="fig"}). These results suggest that mitochondria play a role in the sequestration of Ca^2+^ during phases A and B. Taken together, our results point to a complex and dynamic response to staurosporine, wherein cells mobilize Ca^2+^ from and to the extracellular medium, ER, vacuoles/acidic organelles and mitochondria.

Staurosporine activates phospholipase-C- and IP~3~-mediated recruitment of Ca^2+^ {#s2c}
---------------------------------------------------------------------------------

Phospholipase C converts PIP~2~ into IP~3~ and DAG. IP~3~ acts as a second messenger and, by binding to its receptor, results in Ca^2+^ mobilization from intracellular stores, whereas DAG activates protein kinase C (PKC) ([@b1]). In *N. crassa*, IP~3~ has been reported to promote the release of Ca^2+^ from the ER ([@b77]) and vacuole ([@b20]; [@b77]). Given the importance of phospholipase-C--IP~3~ signaling for hyphal growth ([@b76]; [@b77]; [@b78]), we hypothesized that it could be involved in the fungal response to staurosporine.

We measured \[Ca^2+^\]~c~ dynamics in response to staurosporine treatment in cells pre-treated with the phospholipase-C-selective inhibitor U-73122 ([@b79]). The \[Ca^2+^\]~c~ response over the entire 5-hour timecourse was greatly suppressed ([Fig. 3A,F,G](#f03){ref-type="fig"}), consistent with a significant requirement for phospholipase C during this response. Lithium (LiCl~2~) has been used in *N. crassa* to inhibit inositol monophosphatase, thus preventing the synthesis of phosphoinositides ([@b38]). This inhibition reduces phospholipase C activity owing to the absence of adequate levels of PIP~2~ to be hydrolyzed into IP~3~ and DAG ([@b2]). LiCl~2~ in the presence of staurosporine significantly reduced the \[Ca^2+^\]~c~ peaks during phases A and B and almost completely abolished the \[Ca^2+^\]~c~ increase of phase C ([Fig. 3B,F,G](#f03){ref-type="fig"}). These effects on \[Ca^2+^\]~c~ were very similar to those resulting from the effects of the IP~3~-receptor-selective inhibitor xestospongin C ([@b28]) ([Fig. 3C,F,G](#f03){ref-type="fig"}). This suggests that LiCl~2~ and xestospongin C act by preventing IP~3~ formation and the consequent release of Ca^2+^ from internal stores that seem to participate early on but continue to be involved throughout the entire \[Ca^2+^\]~c~ response to staurosporine. We also tested the effect of 2-APB, which has been previously shown to block an IP~3~-receptor-like channel and hyphal growth in *N. crassa* ([@b77]). 2-APB blocked most of the \[Ca^2+^\]~c~ response to staurosporine, exhibiting a stronger inhibitory effect than xestospongin C ([Fig. 3D,F,G](#f03){ref-type="fig"}). Although 2-APB might be blocking IP~3~-receptor-activated Ca^2+^ release, it is likely that its effects result from the inhibition of TRP channels, as previously claimed ([@b16]). This might explain its different effects on the staurosporine-induced Ca^2+^ signature when compared with the more selective IP~3~ receptor inhibitor xestospongin C. Taken together, these results indicate that staurosporine promotes the activity of phospholipase C and that the recruitment of Ca^2+^ from intracellular stores requires the generation of IP~3~.

![**Staurosporine activates phospholipase-C- and IP~3~-mediated recruitment of Ca^2+^.** (A--E) The influence of pre-treatment with different inhibitors on the Ca^2+^ signature after aequorin-expressing wild-type cells were treated with 20 µM staurosporine (STS). Cells were pre-treated with 10 µM U-73122 (A), 10 mM LiCl~2~ (B), 10 µM xestospongin C (C), 50 µM 2-APB (D) and 10 µM YM-58483 (E). (F,G) Quantification (in arbitrary units, A.U.) of the \[Ca^2+^\]~c~ transients A and B, respectively, which are shown in A--E. Data show the mean±s.e.m.; \**P*\<0.05.](jcs-127-17-3817-f03){#f03}

Because Ca^2+^ influx from the extracellular space can be triggered by the depletion of IP~3~-sensitive Ca^2+^ stores through store-operated Ca^2+^ entry (SOCE, or capacitative Ca^2+^ entry) ([@b71]), we evaluated whether SOCE was triggering the Ca^2+^-release-activated Ca^2+^ channel (CRAC). We pre-treated cells with the CRAC-selective inhibitor YM-58483 ([@b92]) before incubation with staurosporine, and we observed that the beginning of the \[Ca^2+^\]~c~ peak A was present, probably corresponding to the IP~3~-activated intracellular store depletion phase, whereas the second part of the same peak was significantly reduced ([Fig. 3E--G](#f03){ref-type="fig"}). Phase C was also decreased in YM-58483-pre-treated cells. Thus, it seems that the staurosporine-induced Ca^2+^ response in *N. crassa* includes the process of SOCE, which has not been reported in filamentous fungi before.

PLC-2 regulates staurosporine-induced cell death and polarized hyphal growth {#s2d}
----------------------------------------------------------------------------

We examined the sensitivity to staurosporine of the deletion strains for the four predicted phospholipase C genes of *N. crassa* ([@b45]; [@b89]). Interestingly, whereas Δ*plc-1* (ΔNCU06245) and Δ*plc-3* (ΔNCU09655) strains were slightly more resistant, Δ*plc-2* (ΔNCU01266) was substantially more resistant than the wild-type strain ([Fig. 4A](#f04){ref-type="fig"}). We confirmed the increased resistance to staurosporine of Δ*plc-2* cells by measuring the levels of apoptosis with the YO-PRO1 marker ([@b43]). Treatment with staurosporine led to a significant increase in the percentage of apoptotic cells in the wild-type but not in the Δ*plc-2* deletion strain ([Fig. 4B](#f04){ref-type="fig"}). A 2-hour treatment with staurosporine caused ∼23.4% apoptosis in wild-type and ∼9.9% in Δ*plc-2* cells. In the absence of PLC-2, the \[Ca^2+^\]~c~ response to staurosporine was nearly abolished altogether ([Fig. 4C--E](#f04){ref-type="fig"}), paralleling the response in wild-type cells pre-treated with the phospholipase C inhibitor U-73122 ([Fig. 3A](#f03){ref-type="fig"}). These results indicate that phospholipase C is required for staurosporine-induced cell death and support the conclusion that Ca^2+^ signaling is important during the process.

![**PLC-2 is required for the Ca^2+^ signature and for cell death induced by staurosporine, and is involved in *N. crassa* hyphal development.** (A) The sensitivity profiles of deletion strains for the four *N. crassa* phospholipase C genes were evaluated by spotting conidia onto GFS medium containing 2.5 µM staurosporine (STS). The GFS medium contained 2% sorbose to produce compact colonies. (B) The levels of apoptosis in wild-type and Δ*plc-2* cells were detected by staining with YO-PRO1, and the percentage of positive cells was measured by flow cytometry. \**P*\<0.05 (for 50 µM STS versus DMSO for each strain); ^\#^*P*\<0.05 (for STS-treated wild-type versus Δ*plc-2* cells). (C) \[Ca^2+^\]~c~ was measured in aequorin-expressing Δ*plc-2* cells after treatment with 20 µM STS. (D,E) Quantification (in arbitrary units, A.U.) of the \[Ca^2+^\]~c~ transients A and B, respectively, which are shown in C. Data show the mean±s.e.m.; \**P*\<0.05. (F,G) Growth of wild-type and Δ*plc-2* strains in solid medium. The panels show growth at 48 h post-inoculation (F) and hyphal extension rates over time as the mean±s.e.m. (G). (H) Growth of wild-type and Δ*plc-2* strains in liquid medium over 24 hours was obtained by measuring absorbance (Abs) at 450 nm. Data show the mean±s.e.m. (I) Representative micrographs of wild-type and Δ*plc-2* strains at 8 hours and 24 hours after inoculation in liquid Vogel\'s minimal medium. The percentage of germinated cells is indicated in the upper right corner (mean±s.e.m.). Note the presence of swollen conidia and several ungerminated conidia in 24-hour-cultures of Δ*plc-2* (arrows). \**P*\<0.05. Scale bars: 40 µm.](jcs-127-17-3817-f04){#f04}

Radial growth of Δ*plc-2* cells in solid Vogel\'s minimal medium was severely delayed ([Fig. 4F,G](#f04){ref-type="fig"}). Deletion of *plc-2* also resulted in very poor growth in liquid medium ([Fig. 4H](#f04){ref-type="fig"}). After 8 hours of culture, almost all wild-type cells had germinated (95.8%) and normal hyphal elongation was observed ([Fig. 4I](#f04){ref-type="fig"}). By contrast, Δ*plc-2* cells underwent greatly reduced germination (39.7% germination). The difference was also evident after 24 hours of growth; whereas the wild-type strain was fully developed with 99.9% germination and long branched and fused hyphae, the Δ*plc-2* knockout mutant only underwent 58.5% germination, possessed swollen cells and a few elongated branched hyphae with little cell fusion evident. The presence of some germinated hyphae in Δ*plc-2* knockout cultures might be explained by the redundant activity of the other phospholipase C genes, as suggested previously ([@b30]).

Staurosporine activates a putative TRP channel involving Ca^2+^ influx from the external medium {#s2e}
-----------------------------------------------------------------------------------------------

Because SOCE seems to be only partially involved in the staurosporine-induced Ca^2+^ signature ([Fig. 3E](#f03){ref-type="fig"}), we further investigated the mechanism of Ca^2+^ influx responsible for the \[Ca^2+^\]~c~ peaks associated with phases A and B. So far, two Ca^2+^-uptake systems have been established in fungi -- the high- and low-affinity Ca^2+^ uptake systems (HACS and LACS, respectively). At the molecular level, HACS comprises the CCH-1 and MID-1 channel ([@b60]) whereas the channel counterpart in LACS is FIG-1 ([@b61]).

A drastic increase in the \[Ca^2+^\]~c~ peaks associated with phases A and B was observed in aequorin-expressing Δ*cch-1* cells (ΔNCU02762) exposed to staurosporine ([Fig. 5A,C,D](#f05){ref-type="fig"}). This was mainly due to extracellular Ca^2+^ uptake, because it was prevented by pre-treatment with the Ca^2+^-chelator BAPTA ([Fig. 5A,C,D](#f05){ref-type="fig"}). The \[Ca^2+^\]~c~ response in the Δ*fig-1* mutant (ΔNCU02219) was more similar to that of the wild-type cells, despite a slight \[Ca^2+^\]~c~ amplitude increase in phase B and a decrease in phase C ([Fig. 5B--D](#f05){ref-type="fig"}). These data strongly suggest that Ca^2+^ uptake during staurosporine-induced cell death involves channel activity distinct from that of the CCH-1--MID-1 high-affinity system or the FIG-1 low-affinity system. This unknown influx system was stimulated by staurosporine especially in the absence of CCH-1. Remarkably, complete abolition of the staurosporine \[Ca^2+^\]~c~ signature was observed when Δ*cch-1* cells were pre-treated with 2-APB ([Fig. 5A,C,D](#f05){ref-type="fig"}), which is known to inhibit the IP~3~ receptor but also TRP channels ([@b16]). As previously reported ([@b83]), we could not generate a Δ*mid-1* strain expressing aequorin at sufficient levels for \[Ca^2+^\]~c~ measurement. MID-1 (NCU06703) is considered to be a regulatory partner of CCH-1 ([@b42]; [@b55]; [@b60]), although there are reports of MID-1 behaving as a non-selective stretch-activated cation channel protein ([@b12]; [@b46]; [@b54]). Nonetheless, the knockout of *mid-1* phenocopied the *cch-1* deletion, as both strains showed defects such as reduced aerial hyphae, conidiation ([supplementary material Fig. S3A](http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.152058/-/DC1)) and mycelial extension rate ([supplementary material Fig. S3B](http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.152058/-/DC1)), consistent with both proteins acting together.

![**Staurosporine-induced Ca^2+^ influx occurs through an uptake system distinct from the high- and low-affinity Ca^2+^ systems.** (A,B) The Ca^2+^ signature in response to 20 µM staurosporine (STS) was compared in aequorin-expressing wild-type and Δ*cch-1* (A) or Δ*fig-1* (B) cells. The influence of pre-treatment with 4 mM BAPTA and 50 µM 2-APB on the Δ*cch-1* STS-induced Ca^2+^ signature is shown in A. (C,D) Quantification (in arbitrary units, A.U.) of the \[Ca^2+^\]~c~ transients A and B, respectively, which are shown in panels A,B. Data show the mean±s.e.m.; \**P*\<0.05 (for Δ*cch-1* versus wild-type cells); ^\#^*P*\<0.05 (for BAPTA and 2-APB pre-treated Δ*cch-1* cells versus Δ*cch-1* with STS alone). (E) The sensitivity of Δ*cch-1* and Δ*mid-1* strains was evaluated by spotting conidia onto GFS medium containing 2.5 µM STS.](jcs-127-17-3817-f05){#f05}

Given the accentuated Δ*cch-1* \[Ca^2+^\]~c~ signature during phases A and B in response to staurosporine ([Fig. 5A](#f05){ref-type="fig"}), we assessed the susceptibility of Δ*cch-1* and Δ*mid-1* cells to staurosporine and observed that both strains are hypersensitive to the drug ([Fig. 5E](#f05){ref-type="fig"}). This was corroborated by the analysis of the inhibitory effect of staurosporine after measuring both growth in liquid culture ([supplementary material Fig. S3C](http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.152058/-/DC1)) and YO-PRO1 staining to estimate apoptosis ([supplementary material Fig. S3D](http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.152058/-/DC1)). Deletion of *fig-1* resulted in a slight increase in susceptibility to staurosporine ([supplementary material Fig. S4A](http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.152058/-/DC1)). Thus, the upregulation of a Ca^2+^ influx system in the absence of CCH-1 (and possibly MID-1) is correlated with increased cell death.

In animals, Ca^2+^ influx can be mediated by TRP channels, which are known to be regulated by the phospholipase C pathway ([@b73]). Because of the importance of phospholipase C during the response to staurosporine, we asked whether a TRP channel might be involved in the Ca^2+^ influx from the extracellular medium. The presence of flufenamic acid, a chemical that, albeit non-selectively, blocks some TRP channels ([@b36]), nearly abolished the staurosporine-induced \[Ca^2+^\]~c~ signature ([Fig. 6A,E,F](#f06){ref-type="fig"}). We also performed \[Ca^2+^\]~c~ measurements in the presence of Ruthenium Red, a non-selective inhibitor of the MCU and a pan-inhibitor of TRP channels ([@b16]), and found that the \[Ca^2+^\]~c~ response to staurosporine was also strongly suppressed ([Fig. 6B,E,F](#f06){ref-type="fig"}). This is in agreement with our evidence that pre-incubation with 2-APB, an IP~3~-receptor inhibitor but also a blocker of TRP channels ([@b16]), potently reduced the \[Ca^2+^\]~c~ response to staurosporine ([Fig. 3D](#f03){ref-type="fig"}).

![**Staurosporine activates a TRP-like channel responsible for extracellular Ca^2+^ influx.** (A--C) The Ca^2+^ signatures in response to 20 µM staurosporine (STS) in aequorin-expressing wild-type cells after pre-treatment with different Ca^2+^-modulating drugs. Cells were pre-treated with 100 µM flufenamic acid (A, fluf acid), 100 µM Ruthenium Red (B, ruthen red) and 50 µM ML204 (C). (D) The Ca^2+^ signatures in response to 20 µM STS in aequorin-expressing Δ*yvc-1* cells. (E,F) Quantification (in arbitrary units, A.U.) of the \[Ca^2+^\]~c~ transients A and B, respectively, which are shown in A--D. Data show the mean±s.e.m.; \**P*\<0.05.](jcs-127-17-3817-f06){#f06}

Because our data provides evidence that phospholipase C is activated by staurosporine and that the consequent depletion of PIP~2~ is an activation factor for a specific TRP channel, TRPC4 ([@b91]), we analyzed the \[Ca^2+^\]~c~ response to staurosporine in the presence of ML204, a specific antagonist of TRPC4 and TRPC5 ([@b59]). With this inhibitor, the \[Ca^2+^\]~c~ peaks associated with phases B and C were significantly reduced ([Fig. 6C,E,F](#f06){ref-type="fig"}). The effect of ML204 was not as drastic as that of the other TRP inhibitors, and this might be explained by the fact that it is very selective against mammalian TRPC4 and TRPC5 ([@b59]) and no obvious sequence homologs are present in *N. crassa*. Taken together, the differences in the \[Ca^2+^\]~c~ response to staurosporine-induced cell death in the presence of flufenamic acid, Ruthenium Red, 2-APB, ML204, BAPTA and U-73122, along with the deficient Ca^2+^ response of the Δ*plc-2* mutant strain, suggest that staurosporine induces the opening of a TRP-like channel regulated by phospholipase C.

So far, the only TRP channel reported in *N. crassa* has been YVC-1 (NCU07605 or NCU16725 in a recent annotation) ([@b89]). The initial part of the staurosporine-induced \[Ca^2+^\]~c~ signature was similar in wild-type and Δ*yvc-1* cells (phases A and B), but \[Ca^2+^\]~c~ during phase C was decreased in Δ*yvc-1* cells ([Fig. 6D--F](#f06){ref-type="fig"}). The growth of Δ*yvc-1* was inhibited by staurosporine, similar to that of the wild-type strain ([supplementary material Fig. S4B](http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.152058/-/DC1)). A role for this protein in extracellular Ca^2+^ uptake would not be expected, because the yeast homolog is localized to the vacuolar membrane and this channel mobilizes Ca^2+^ from the vacuole to the cytosol ([@b67]). Thus, our combined pharmacological and genetic approach points to the existence of a Ca^2+^-permeable channel that has properties of a TRP-like channel, is distinct from YVC-1 and is the mediator of Ca^2+^ influx from the extracellular medium during staurosporine-induced cell death.

DISCUSSION {#s3}
==========

The model organism *N. crassa* undergoes programmed cell death accompanied by the manifestation of several cellular phenotypes, such as DNA fragmentation, accumulation of reactive oxygen species (ROS), ceramide synthesis, compartmentalization of cells, glutathione export and activation of multidrug resistance proteins ([@b10]; [@b9]; [@b22]; [@b26]; [@b25]; [@b32]; [@b69]; [@b85]). Here, we show that staurosporine, an archetypal cell death inducer of therapeutic interest, activates a complex and dynamic intracellular response involving the influx of extracellular Ca^2+^ as well as the cytosolic recruitment of Ca^2+^ from intracellular stores. At the molecular level, this is promoted by a putative novel TRP-like channel and phospholipase C (probably PLC-2), which trigger a Ca^2+^ response with a characteristic \[Ca^2+^\]~c~ signature. Some reports have shown an increase in \[Ca^2+^\]~c~ in response to staurosporine ([@b23]; [@b39]; [@b51]; [@b64]; [@b65]; [@b75]), but the underlying mechanisms remain largely unknown. Recent research has shown that staurosporine, as well as its clinically relevant analog PKC412, induces Ca^2+^ influx through the hyperpolarization-activated cyclic nucleotide-gated channel HCN2 in human lung cancer cells and neurons ([@b65]). No HCN2 homologs are known in *N. crassa*.

Our data indicate that staurosporine triggers the activation of phospholipase C by a currently unknown mechanism. Possible phospholipase C activation mechanisms include membrane stretch ([@b50]), interaction with G-protein-coupled receptors ([@b87]) and liberation from phosphorylation by PKC ([@b74]). Given that staurosporine is a powerful inhibitor of PKC ([@b66]), it is tempting to propose that it is the alleviation of the phosphorylation of phospholipase C by PKC that prompts the onset of the response. As a consequence of its activation, phospholipase C hydrolyses PIP~2~ with three outcomes -- depletion of PIP~2~, generation of DAG and generation of IP~3~, all of which affect the activity of TRP channels ([@b73]). First, the depletion of PIP~2~ controls TRP proteins, although the mode of regulation depends on the specific identity of the channel; in animals, the depletion of PIP~2~ inhibits TRPC3, TRPC6 and TRPC7 ([@b52]), whereas it activates TRPC4 ([@b91]). Other channels, like TRPC5 and TRPV1 have been shown to be both negatively and positively regulated by PIP~2~ depletion, depending on the cellular environment ([@b73]). Our results support the hypothesis that phospholipase C depletes PIP~2~ and this causes the opening of a channel that behaves like TRPC4. Indeed, TRPC4 was shown to be inhibited by PKC ([@b84]), and we found that the selective TRPC4 antagonist ML204 partially reduced the \[Ca^2+^\]~c~ response to staurosporine. In the presence of staurosporine, PKC is inhibited ([@b66]), and this would relieve the inhibition of a TRPC4-like channel, allowing it to open. PIP~2~ depletion also affects TRPV1 ([@b14]), but the existing data are conflicting on whether the reduction in PIP~2~ activates or inactivates the channel ([@b73]). Second, the generation of DAG might not have a significant role in our system, because DAG activates PKC, which is blocked by staurosporine alone ([@b66]). We cannot exclude that DAG is acting directly on TRP channels as shown previously ([@b40]; [@b84]). Nonetheless, it was shown that this PKC-independent direct interaction of DAG with TRP channels is protein specific and does not occur in members of the family such as TRPC4 and TRPC5 ([@b84]). If indeed there is a TRPC4-like channel involved in staurosporine-induced cell death, it is more likely that PIP~2~ depletion is the major regulatory mechanism. In accordance with our results, inositol starvation triggers ER-mediated cell death in fission yeast ([@b35]). The generation of IP~3~ after treatment with staurosporine led to the mobilization of Ca^2+^ from internal stores, in line with the observation that during part of the response the ER contributes to the increase in \[Ca^2+^\]~c~.

The genome of *N. crassa* encompasses four putative phospholipase C (δ-type) genes ([@b45]; [@b89]). Of the four, only PLC-1 was previously characterized, and it seems to be implicated in aspects of cell morphogenesis not involving polarized hyphal growth ([@b30]). We observed that the absence of *plc-2* leads to aberrant spore germination and that it plays an important role in hyphal growth. Evidence has been previously presented from studies on *N. crassa* that support the idea that the IP~3~-mediated mobilization of Ca^2+^ from intracellular ER and Golgi-derived vesicles is involved in the maintenance of the tip-high Ca^2+^ gradient, which is reported to be required for hyphal elongation ([@b77]). Our results suggest that PLC-2 might be the main phospholipase C engaged in this process. Recent observations in other filamentous fungi, however, have raised questions about the presence, and thus requirement, of a constant tip-high \[Ca^2+^\]~c~ gradient in continuously growing hyphae ([@b49]). These authors have shown that transient \[Ca^2+^\]~c~ spikes occur in growing hyphal tips instead, but their role in hyphal elongation and the requirement for PLC-2 in generating these spikes is currently unclear. Other studies have shown that deletion of phospholipase C genes in *Magnaporthe oryzae* results in defects in other morphogenetic processes, such as appressorium formation and conidiation ([@b13]; [@b72]).

In *N. crassa*, treatment with the antifungal peptide PAF ([@b4]) or with the bacterial metabolite 2,4-diacetylphloroglucinol (DAPG) ([@b83]) leads to Ca^2+^ influx from the external medium in a CCH-1-independent manner. DAPG-induced Ca^2+^ influx has also been shown to be independent of FIG-1, whereas this was not tested for PAF. Cell-survival-associated Ca^2+^ uptake, mediated by an unidentified channel, has been shown to occur in parallel with Ca^2+^ entry through Cch1--Mid1 in yeast treated with tunicamycin, an ER stress agent ([@b5]). There is thus evidence for the presence of fungal Ca^2+^ uptake systems in addition to the already characterized HACS (CCH-1 and MID-1) and LACS (FIG-1) mechanisms ([@b11]; [@b42]; [@b55]; [@b56]; [@b60]; [@b61]). Here, we describe a putative Ca^2+^ channel in the plasma membrane with the pharmacological properties of a TRP protein. This represents a novel mechanism for Ca^2+^ influx in fungi, and it is conceivable that it might be involved in some or all of these aforementioned responses. The only TRP channel so far described in *N. crassa* is YVC-1 ([@b89]), although a few proteins were recently proposed as putative homologs of the mammalian TRP channels in pathogenic fungi ([@b70]). It is not plausible that YVC-1 is the channel activated by staurosporine because the respective knockout mutant does not show major differences from wild-type cells in terms of the \[Ca^2+^\]~c~ response to staurosporine and, furthermore, yeast Yvc1 is localized in the vacuole ([@b67]). The TRP Ca^2+^ uptake system seems to be more active in the absence of CCH-1. Possibly as a consequence of this upregulation in Ca^2+^ uptake, cells lacking CCH-1 (and MID-1) undergo more cell death than the wild-type cells when treated with staurosporine. This is consistent with the observation that Δ*cch-1* and Δ*mid-1* cells are less tolerant to high levels of Ca^2+^ ([supplementary material Fig. S3E](http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.152058/-/DC1)). In line with our results, lack of CCH-1 and MID-1 renders *S. cerevisiae* and *Cryptococcus neoformans* cells very sensitive to ER stress caused by tunicamycin or azole drugs ([@b5]; [@b41]; [@b56]).

A model illustrating the mechanisms involved in staurosporine-induced and phospholipase-C-mediated cell death is presented in [Fig. 7](#f07){ref-type="fig"}. We propose that the staurosporine-induced increase in the \[Ca^2+^\]~c~ is caused by continuous Ca^2+^ influx from the external medium (through an unidentified TRP-like channel and SOCE) and release of Ca^2+^ from internal stores by a variety of mechanisms. The action of staurosporine includes the activation of phospholipase C, which leads to the generation of IP~3~ and possibly to the regulation of the TRP-like channel. The vacuoles readily sequester the excess Ca^2+^ in an attempt to avoid the associated deleterious effects of Ca^2+^. This sequestration can occur by means of a Ca^2+^/H^+^ antiport system that is indirectly blocked by the disruptive effect of bafilomycin A1 on the proton gradient by inhibiting the vacuolar H^+^-ATPase ([@b17]; [@b18]). Sequestration of Ca^2+^ through this system seems to eventually saturate because bafilomycin A1 does not block the C phase of the staurosporine-induced Ca^2+^ signature. Interestingly, recent reports demonstrate that the vacuolar H^+^/ATPase is a central mediator of cell death in fungal ([@b48]; [@b90]) and cancer ([@b86]) cells. In *S. cerevisiae*, cells lacking vacuolar ATPase activity are very sensitive even to brief elevations in \[Ca^2+^\]~c~ ([@b27]). In future studies, it will be interesting to determine the role of the vacuolar H^+^-ATPase in *N. crassa* cell death.

![**A proposed model for the action of staurosporine in *N. crassa*.** See [Discussion](#s3){ref-type="sec"} for details. Blue circles, Ca^2+^; M, mitochondria; ER, endoplasmic reticulum; V, vacuoles; ROS, reactive oxygen species; GSH, reduced glutathione; SOCE, store-operated Ca^2+^ entry; STS, staurosporine.](jcs-127-17-3817-f07){#f07}

Mitochondrial fluxes of Ca^2+^ also seem to be involved in the response to staurosporine. The initial changes in the staurosporine-induced Ca^2+^ signature when the MCU is inhibited with Ru360 suggest that mitochondria play an early role in Ca^2+^ sequestration. However, \[Ca^2+^\]~c~ peaks B and C are reduced in the presence of Ru360, suggesting that the role of mitochondria is not restricted to Ca^2+^ sequestration but also involves either direct release of Ca^2+^ into the cytosol or the ER through the so-called microdomains of contact between the two organelles ([@b15]). Interestingly, thapsigargin-treated cells generated the opposite response to those treated with Ru360, because the amplitudes of the \[Ca^2+^\]~c~ transients increased during phases B and C. These results can be possibly explained by the hypothesis that mitochondria and ER exhibit Ca^2+^ crosstalk over long periods by transporting Ca^2+^ ions between them. The apparent paradoxical conclusion that the ER is releasing Ca^2+^ through an IP~3~-activated channel but sequestering the ion at the same time (especially during phase B, see the staurosporine-induced cytosolic \[Ca^2+^\]~c~ transient in thapsigargin-treated cells, [Fig. 2B](#f02){ref-type="fig"}) might be explained by a tunneling mechanism by which the ER can load with Ca^2+^ through contact spots between mitochondria and ER, and almost instantaneously release Ca^2+^ from regions of the ER that are rich in IP~3~-activated channels ([@b68]). Extracellular Ca^2+^ uptake continues throughout the whole duration of the response to staurosporine, as deduced from the experiments involving treatment with the Ca^2+^-chelator BAPTA. Our model also illustrates that the extent of staurosporine-induced cell death is determined by the activity of the staurosporine-exporting ATP-binding cassette transporter ABC3 ([@b25]), which is under the control of the transcription factor CZT-1 ([@b33]). ROS accumulation is also controlled by CZT-1 ([@b33]) and is required for staurosporine-induced cell death, which, in turn, is facilitated by the efflux of reduced glutathione (GSH) ([@b10]; [@b26]).

This study has made extensive use of inhibitors that are commonly used to experimentally manipulate Ca^2+^ signaling in mammalian cells, and some of these drugs lack specificity against their purported targets. Therefore, some caution needs to be taken with regard to the interpretation of results from the inhibitor experiments, especially because the precise targets of these inhibitors in fungal cells have not been characterized in detail. Of the inhibitors employed in our study, several have been previously used in *N. crassa* -- thapsigargin ([@b37]), bafilomycin A1 ([@b7]) and U-73122 ([@b77]). Ru360, xestospongin C, YM-58483 and ML204 have not been used previously with *N. crassa* cells but are known to be very selective in animal cells ([@b28]; [@b44]; [@b57]; [@b59]). Despite these limitations, our pharmacological results are consistent with those obtained using a genetic approach.

Staurosporine is a widely used tool in cell death research and a prototype for anticancer drugs ([@b29]). Thus, characterization of its mechanism of action might impact on future studies on the fundamental aspects of signaling during cell death and on the development of therapeutic treatments for fungal infection and cancer.

MATERIALS AND METHODS {#s4}
=====================

Strains, culture media and chemicals {#s4a}
------------------------------------

*N. crassa* was handled according to standard procedures. Vogel\'s minimal medium plus 1.5% (w/v) sucrose was used in all experiments ([@b21]). Wild-type and deletion strains used in this study are listed in [supplementary material Table S1](http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.152058/-/DC1). The following chemicals were used: staurosporine (LC Laboratories, Woburn, MA); DMSO, ML204, flufenamic acid and xestospongin C (Sigma-Aldrich, St Louis, MO); 4-methyl-4′-\[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl\]-1,2,3-thiadiazole-5-carboxanilide (YM-58483/BTP2) and 2-aminoethoxydiphenyl borate (2-APB) (Tocris Bioscience, Bristol, UK); 1,2-bis(ortho-aminophenoxy)ethane-N,N,N′,N′-tetrasodium (BAPTA), thapsigargin, Ru360, LiCl~2~ and 7-hydroxystaurosporine (UCN-01) (Merck Millipore, Darmstadt, Germany); 1-\[6-((17β-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl\]-1H-pyrrole-2,5-dione (U-73122) (Alexis Biochemicals, San Diego, CA) and bafilomycin A1 (Wako Chemicals, Richmond, VA).

Mycelial extension rates at 26°C were measured after inoculating 5 µl containing 1×10^3^ conidia onto the centre of large Petri dishes (14.2-cm diameter) containing solid minimal medium. For growth measurements in liquid minimal medium, 1×10^4^ conidia/ml were incubated at 26°C, 100 rpm, under constant light in 96-well plates (200 µl total volume per well) and absorbance was monitored at 450 nm over 24 hours.

Intracellular Ca^2+^ measurement with aequorin {#s4b}
----------------------------------------------

Genetically encoded Ca^2+^ reporters are the most reliable option for the study of intracellular Ca^2+^ dynamics, and such a method was developed for filamentous fungi using the bioluminescent Ca^2+^ reporter aequorin that has been codon-optimized for *N. crassa* ([@b63]). The pAB19 vector containing the gene encoding the synthetic aequorin was used to transform *N. crassa* cells by electroporation with an Eppendorf Multiporator (Hamburg, Germany) at 1800 V for 5 ms. Aequorin-expressing conidia were obtained and incubated at a concentration of 2×10^6^ cells/ml with 5 µM coelenterazine (Santa Cruz Biotechnology, Dallas, TX) in minimal medium. Aliquots of 100 µl were added to each well of white opaque 96-well plates and incubated for 6 hours at 26°C in the dark without agitation. The luminescence emitted was measured in relative light units (RLU) using a Bio-Tek Synergy HT (Winooski, VT) microplate reader. Owing to equipment constraints, it was not possible to convert RLU values into precise \[Ca^2+^\]~c~ concentrations. Therefore, the luminescence results were normalized for each strain to allow direct comparisons between different experiments as follows. For each strain, 100 µl of 3 M CaCl~2~ in 20% ethanol was pipetted into extra wells of the 96-well plates and discharged aequorin luminescence was measured for 3 minutes. This provided a measurement of the total aequorin luminescence that could be emitted and corresponds to the maximum level of aequorin expressed for each strain in each experiment. These total aequorin discharge measurements were used to normalize the experimental RLU values for each strain \[cytosolic Ca^2+^ levels (arbitrary units) = experimental RLU values/total emitted luminescence\]. For each plot of the values of aequorin luminescence, as a readout of \[Ca^2+^\]~c~, quantification was performed by summing the normalized experimental values, and data are expressed as the mean±s.e.m. The RLU values of solvent DMSO control samples were subtracted from the RLU values of the staurosporine-treated samples to obtain the 'staurosporine-induced Ca^2+^ amplitude of response'. Where specified, samples were pre-incubated for 15 minutes with various pharmacological agents before staurosporine (or DMSO) was added. In all instances, the volume of chemical(s) added to the wells was 10 µl (from an appropriate stock solution), to ensure good homogenization. The aequorin luminescence plots presented in this paper correspond to the average of at least three independent experiments with three to six replicates per experiment. The typical staurosporine-induced Ca^2+^ signature of wild-type cells was obtained from 30 independent experiments.

Cell death assays {#s4c}
-----------------

For the spot assay, nine successive threefold dilutions were prepared for each strain starting with 6.6×10^7^ cells/ml. From each dilution, 5 µl was spotted onto plates containing glucose-fructose-sorbose (GFS) medium with agar supplemented with the indicated chemical. Cells were incubated at 26°C and images were obtained 72 hours later.

For the detection of apoptotic cells by flow cytometry, the fluorophore YO-PRO1 (Life Technologies, Carlsbad, CA) was used. Conidia at a concentration of 10^6^ cells/ml were cultured for 4 hours in Vogel\'s minimal medium at 26°C, 140 rpm, under constant light conditions, followed by the addition of staurosporine and growth for a further 2 hours. Samples were harvested by centrifugation, washed twice with PBS and incubated with 0.1 µM YO-PRO 1. After 20 minutes on ice, samples were read in a Beckman-Coulter EPICS XL-MCL (Brea, CA). Results represent the mean±s.e.m.

Microscopy {#s4d}
----------

For routine microscopy, a Nikon TE2000E inverted microscope with a 60×/1.2 NA water-immersion plan apo objective (Nikon, Kingston-upon-Thames, UK) and differential interference contrast (DIC) optics was used. For these analyses, 200-µl drops of conidial suspension in liquid Vogel\'s medium containing 5×10^5^ conidia/ml were placed in eight-well slide culture chambers (Nalg Nunc, Rochester, NY) and incubated at 26°C. Images were captured with an ORCA-ER CCD camera (Hamamatsu, Welwyn Garden City, UK) driven by the MetaMorph NX1.1 software for image acquisition. The percentage of germinated cells was calculated using ImageJ (NIH, Bethesda, MD).

For the evaluation of propidium iodide uptake by dead cells, conidia at a concentration of 2×10^6^ cells/ml were incubated in eight-well slide chambers at 26°C in the dark without agitation and stained with 5 µg/ml propidium iodide (Sigma-Aldrich). After 6 hours of growth, 20 µM staurosporine or DMSO was applied and images were obtained at appropriate time-points. Micrographs were obtained using an Olympus IX81 inverted fluorescence microscope (Tokyo, Japan) equipped with DIC optics. Fluorescence images were acquired using a plan fluor 20×/0.45 NA objective lens, using a 100-W mercury fluorescence light source and a BP 510--550 excitation filter; fluorescence emission was filtered through a dichroic mirror DM570 (Olympus, Tokyo, Japan). Images were acquired with a cooled CCD camera (ColorView II, Soft Imaging System GmbH, Münster, Germany) connected to a computer running Cell F (Olympus, Tokyo, Japan). The exposure time was adjusted to 50 ms without binning. The percentage of propidium-iodide-positive cells was quantified using ImageJ (NIH) and expressed as the mean±s.e.m.

Statistical analysis {#s4e}
--------------------

Statistical analysis of the data was performed using SPSS 20 (SPSS, Chicago, IL). The non-parametric Mann--Whitney test was used for comparisons between two groups. *P*-values of ≤0.05 were considered statistically significant.
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